Analysis shows lack of evidence that wearable biosensors improve patient outcomes

17-Jan-2018 - Wearable biosensors have grown increasingly popular as many people use them in wristbands or watches to count steps or track sleep. But there is not enough proof that these devices are improving patient outcomes such as weight or blood pressure, according to a study by Cedars-Sinai ...

How food preservatives may disrupt human hormones and promote obesity

Innovative stem-cell testing system demonstrates potential for evaluating health effects of chemicals used in everyday life

11-Aug-2017 - Can chemicals that are added to breakfast cereals and other everyday products make you obese? Growing evidence from animal experiments suggests the answer may be "yes." But confirming these findings in humans has faced formidable obstacles - until now. A new study published in Nature ...

Researchers identify drugs with fewest side-effects for treating irritable bowel syndrome

27-Mar-2012 - Cedars-Sinai researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen ...

Study of Williams syndrome patients reveals specific gene's role in intelligence

University of Utah Brain Institute researcher leads multi-institution team in groundbreaking study

26-Apr-2010 - Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah (U of U) USTAR researcher has found that the brain gene STX1A plays a significant role in the ...

Study identifies biomarker that safely monitors tumor response to new brain cancer treatment

Gene therapy technique developed in animal model by Cedars-Sinai research team uses immune cells to attack glioblastoma multiforme

02-Jul-2009 - A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in Clinical Cancer Research, paves the way for a Phase 1 clinical ...